Cargando…
Characterization of glycan substrates accumulating in GM1 Gangliosidosis
INTRODUCTION: GM1 gangliosidosis is a rare autosomal recessive genetic disorder caused by the disruption of the GLB1 gene that encodes β-galactosidase, a lysosomal hydrolase that removes β-linked galactose from the non-reducing end of glycans. Deficiency of this catabolic enzyme leads to the lysosom...
Autores principales: | Lawrence, Roger, Van Vleet, Jeremy L., Mangini, Linley, Harris, Adam, Martin, Nathan, Clark, Wyatt, Chandriani, Sanjay, LeBowitz, Jonathan H., Giugliani, Roberto, d'Azzo, Alessandra, Yogalingam, Gouri, Crawford, Brett E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838976/ https://www.ncbi.nlm.nih.gov/pubmed/31720227 http://dx.doi.org/10.1016/j.ymgmr.2019.100524 |
Ejemplares similares
-
Intracerebroventricular enzyme replacement therapy with β-galactosidase reverses brain pathologies due to GM1 gangliosidosis in mice
por: Chen, Joseph C., et al.
Publicado: (2020) -
GM1 Gangliosidosis—A Mini-Review
por: Nicoli, Elena-Raluca, et al.
Publicado: (2021) -
Natural history study of glycan accumulation in large animal models of GM2 gangliosidoses
por: Cavender, Catlyn, et al.
Publicado: (2020) -
Myelin Abnormalities in the Optic and Sciatic Nerves in Mice With GM1-Gangliosidosis
por: Heinecke, Karie A., et al.
Publicado: (2015) -
Clinical findings in Brazilian patients with adult GM1 gangliosidosis
por: Giugliani, Luciana, et al.
Publicado: (2019)